Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?

about

Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?

Item

http://www.wikidata.org/entity/Q58772783

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 23 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Secondary Dyslipidemia In Obes ...... For Pharmacological Treatment?

@en

Secondary Dyslipidemia In Obes ...... For Pharmacological Treatment?

@nl

type

Item

label

Secondary Dyslipidemia In Obes ...... For Pharmacological Treatment?

@en

Secondary Dyslipidemia In Obes ...... For Pharmacological Treatment?

@nl

prefLabel

Secondary Dyslipidemia In Obes ...... For Pharmacological Treatment?

@en

Secondary Dyslipidemia In Obes ...... For Pharmacological Treatment?

@nl

P1476

Secondary Dyslipidemia In Obes ...... For Pharmacological Treatment?

@en

P2093

Claudia Ciceri Cesa

http://www.w3.org/2001/XMLSchema#string

Graciane Radaelli

http://www.w3.org/2001/XMLSchema#string

Grasiele Sausen

http://www.w3.org/2001/XMLSchema#string

Lucia Campos Pellanda

http://www.w3.org/2001/XMLSchema#string

P2860

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

Statins for children with familial hypercholesterolemia

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Development of food preferences.

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.

Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials.

Drug therapy of hypercholesterolaemia in children and adolescents.

Atherogenic dyslipidemia and cardiovascular risk factors in obese children

Use of statins for dyslipidemia in the pediatric population.

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

P304

356-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5935/ABC.20180155

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Vera Lucia Portal

P577

2018-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30156604

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

dyslipidemias

P932

6173338

http://www.w3.org/2001/XMLSchema#string